Cognitive state, substance use patterns and outcome after discharge from Kfar Izun, a unique rehabilitation facility.

Journal of Addictive Diseases
Alon RichterEinat Peles

Abstract

We studied cognitive performance following discharge from a novel rehabilitation facility, treating individuals with psychosis that developed during trips abroad following mandatory military service. Montreal Cognitive Assessment (MoCA), phonetic and semantic fluency, State-Trait Anxiety, and self-Efficiency were administered before discharge, and 3 and 6 months after discharge. Of the 43 participants (30.2% females), 23(54.8%) had cognitive impairment (MoCA <27), and 15(35.7%) had poor phonetic fluency. Anxiety trait and state were high and inversely correlated with self-efficacy (R=-0.48, p = 0.001) and phonetic fluency (R=-0.43, p = 0.004) and was higher among those who experienced physical exposure, females, and those who served in non-combat army units. Six months after discharge, of 32 participants, 28 were working/studying with a 58.1% reduction in smoking and alcohol consumption, and 16 participants stopped substance use. Phonetic fluency improved among the high anxiety state group with no change among the others. High anxiety levels lowered among those who were still using drugs after six months. The anxiety level lowered and 87.1% of the participants were conducting a productive lifestyle at 6 months after discharge, ...Continue Reading

References

Aug 7, 2003·Journal of the International Neuropsychological Society : JINS·Igor GrantTanya Wolfson
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Jun 7, 2005·Pharmacology, Biochemistry, and Behavior·Eliot L Gardner
Oct 5, 2006·Psychopharmacology·Mohini Ranganathan, Deepak Cyril D'Souza
Aug 19, 2007·Neuropsychology Review·J Cobb ScottIgor Grant
May 5, 2010·The American Journal of Psychiatry·Joseph M Pierre
Feb 16, 2011·Journal of Addiction Medicine·Rebecca D CreanBarbara J Mason
Jun 27, 2012·Experimental and Clinical Psychopharmacology·Amy M Schreiner, Michael E Dunn
Aug 1, 2013·Addictive Behaviors·H J LiangW K Tang
Aug 21, 2013·Neuropharmacology·Daniele Piomelli
Jun 11, 2014·Current Opinion in Pediatrics·Scott E Hadland, Sion K Harris
Sep 5, 2014·Journal of Addiction Medicine·Stéphane PotvinJulie Pelletier
Sep 16, 2014·Drug and Alcohol Dependence·Marisol S CastanetoMarilyn A Huestis
Dec 3, 2014·Biological Psychiatry·Catherine FassbenderRuth Salo
Dec 3, 2014·Pharmacology & Therapeutics·Dan I LubmanMurat Yücel
Jan 21, 2015·Drug and Alcohol Dependence·Chih-Ken ChenLiang-Jen Wang
Aug 5, 2015·Therapeutic Advances in Psychopharmacology·David BaumeisterDerek K Tracy
Aug 25, 2015·Journal of Clinical and Experimental Neuropsychology·Gitit Kavé, Ariel Knafo-Noam
May 14, 2016·Current Opinion in Psychiatry·Jrgen G Bramness, Eline B Rognli
Feb 22, 2017·Journal of the American Academy of Child and Adolescent Psychiatry·Amir LevineJeffrey Lieberman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here